Resources

RAPID ADVICE ON THE USE OF NEW ANTI-TUBERCULOSIS FIXED-DOSE COMBINATION TABLETS FOR CHILDREN IN NIGERIA.

THIS IS, "THE NEW ANTI-TB DRUG FORMULATIONS FOR CHILDREN: STRATEGIES FOR ROLL-OUT IN NIGERIA",

PRESENTED BY  DR. URHIOKE OCHUKO OF THE NTBLCP, ON THE 24TH OF JANUARY, 2018 AT THE PAEDIATRIC ASSOCIATION OF NIGERIA/UNAPSA CONFERENCE, HELD AT THE INTERNATIONAL CONFERENCE CENTRE, ABUJA.

This is a document showing the 391 NTBLCP GeneXpert sites as at the end of Quarter 2, 2018.

STANDARD OPERATING PROCEDURES (SOPs) FOR Programmatic Management of Drug Resistant Tuberculosis (PMDT)

This document is therefore developed to enhance the training of all persons expected to use the e-TB Manager at all levels. All stakeholders intending to support the deployment and use of the e-TB Manager are hereby enjoined to use this document in providing capacity building for their intended participants across the country.

GUIDELINES ON THE USE OF THE SHORTER REGIMEN AND NEW DRUGS IN THE CLINICAL AND PROGRAMMATIC MANAGEMENT OF DRUG RESISTANT TUBERCULOSIS AND CO-INFECTIONS OF NIGERIA.

This document describes the steps necessary to implement shorter regimen and new drugs for DR­ TB treatment including diagnosis and bacterial confirmation of drug resistance, treatment regimen design, monitoring of treatment efficacy and safety, and programmatic evaluation.